Ukrainian Court Rules in Favor of Austrian Drug Maker in Patent Infringement Case
Dec 27 2013 - 12:42
On November 11, the Kiev Commercial Court ruled in favor of the Austrian pharmaceutical company Megainpharm, banning the Ukrainian competitor Darnytsia from selling the medication Oftamirine, produced by using the technology patented by Megainpharm.
The first-instance court has also ordered the Ukrainian Ministry of Health to cancel the registration of the drug Oftamirine, used for treating eye infections.
At press time, we did not have information on whether an appeal had been filed against the decision.
Prepared by: Maya Kryvoshei
For more information, please contact firstname.lastname@example.org.
Source: Capital.ua, Ukrainian news portal
Read more news on Ukraine or . Get our latest IP news or browse IP News Eastern Europe Archives.
December 2013 News
- Serbia to Amend Copyright Law
- Montenegro Strengthens Enforcement Against Industrial Design Infringement
- Ukrainian Court Rules in Favor of Austrian Drug Maker in Patent Infringement Case
- Estonian National Patent Data Added to PATENTSCOPE
- Czech Republic and Finland Launch Patent Prosecution Highway
- Russian PTO Joins TMClass
- Croatia Amends Copyright Law
- Macedonian Police Seize 18,000 Pairs of Counterfeit Footwear
- Fake Skullcandy Earphones and Pepsi Radios Destroyed in Slovenia
- Romanian Customs Seize EUR 1.5M Worth of Counterfeits
- Slovenia Amends Industrial Property Act
- New Official Fees in Russia
- Slovak IPO Launches New E-Filing Services